Drug Shortage Report for CEREBYX
| Report ID | 213247 |
| Drug Identification Number | 02230988 |
| Brand name | CEREBYX |
| Common or Proper name | Cerebyx 10ml |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FOSPHENYTOIN SODIUM |
| Strength(s) | 75MG |
| Dosage form(s) | SOLUTION LIQUID |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1x10ml |
| ATC code | N03AB |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-13 |
| Estimated end date | 2024-01-31 |
| Actual end date | 2024-01-30 |
| Shortage status | Resolved |
| Updated date | 2024-01-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-01-31 | English | Compare |
| v5 | 2024-01-30 | French | Compare |
| v4 | 2024-01-30 | English | Compare |
| v3 | 2023-12-14 | English | Compare |
| v2 | 2023-12-13 | French | Compare |
| v1 | 2023-12-13 | English | Compare |
Showing 1 to 6 of 6